Login / Signup

Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

Efstathios KastritisEvangelos TerposZoi EvangelakouFoteini TheodorakakouDespina FotiouMaria S ManolaDespoina D GianniouTina BagratuniNikolaos KanelliasMagdalini MigkouMaria GavriatopoulouIoannis P TrougakosMeletios- Athanasios Dimopoulos
Published in: American journal of hematology (2021)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • dengue virus
  • multiple myeloma
  • mesenchymal stem cells
  • bone marrow
  • coronavirus disease